AnalystsInsight

Ben Pirie (Atrium Research): Analyst Track Record and Price‑Target Accuracy

How often Ben Pirie’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 8 ratings, compared with the average Wall Street analyst.

3 min readHow we research

Key takeaways

  • Ben Pirie ranks #58 of 1,000 analysts in Exent’s scoring (5.0★).
  • 0.0% of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: — days; — of calls were up 12 months later.
  • Most‑covered stocks: TSXV-OMG, TSX-MSA, TSXV-CAPT, TSXV-SPA.

Ben Pirie’s track record at a glance

Ben Pirie of Atrium Research ranks #58 of the 1,000 analysts Exent scores, with a 5.0★ rating and a focus on materials. Over a 7‑year lookback, 0.0% of Ben’s price targets were reached, 52.4 points below the 52.4% average across all analysts.

MetricBen PirieAll analysts
Price‑target hit rate0.0%52.4%
Median days to hit target—91 days
Calls up after 12 months—64.0%
Median 12‑month return of calls—+13.4%
Hit rate, last 2 years0.0%—
Average worst drop after a call−41.3%—
Ratings in the sample8—
Stocks covered34—

How fast price targets were reached

Time to reach the targetBen Pirie
Under 30 days—
30–90 days—
90–180 days—
Over 180 days—

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Ben Pirie covers most

StockRatings in the sample
TSXV-OMG33
TSX-MSA33
TSXV-CAPT32
TSXV-SPA32
TSXV-MTT30
TSXV-CUU25
TSXV-EDG21
TSX-ARG19

In the past year Ben’s ratings were 100% Buy, 0% Hold and 0% Sell.

Recent ratings (shown with a 30-day delay)

DateStockActionRatingPrice target
Sep 14, 2026TSXV-ZENInitiated Coverage: BuyBuy$2.70
Sep 14, 2026TSX-ARGReiterated: BuyBuy$10.00
Sep 9, 2026TSXV-NIMReiterated: BuyBuy$1.50
Sep 2, 2026TSXV-AZTReiterated: BuyBuy$0.45
Sep 2, 2026TSXV-CUUReiterated: BuyBuy$1.30
Sep 1, 2026TSXV-OMGReiterated: BuyBuy$4.25
Aug 31, 2026TSXV-NIMReiterated: BuyBuy$1.50
Aug 26, 2026TSXV-FISHReiterated: BuyBuy$0.00
Aug 25, 2026TSX-RIOReiterated: BuyBuy$5.75
Aug 20, 2026TSXV-OMGReiterated: BuyBuy$4.25
Aug 20, 2026TSXV-MTTReiterated: BuyBuy$0.30
Aug 20, 2026TSXV-LIOReiterated: BuyBuy$0.60
  • Sep 14, 2026
    Stock
    TSXV-ZEN
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $2.70
  • Sep 14, 2026
    Stock
    TSX-ARG
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $10.00
  • Sep 9, 2026
    Stock
    TSXV-NIM
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $1.50
  • Sep 2, 2026
    Stock
    TSXV-AZT
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $0.45
  • Sep 2, 2026
    Stock
    TSXV-CUU
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $1.30
  • Sep 1, 2026
    Stock
    TSXV-OMG
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $4.25
  • Aug 31, 2026
    Stock
    TSXV-NIM
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $1.50
  • Aug 26, 2026
    Stock
    TSXV-FISH
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $0.00
  • Aug 25, 2026
    Stock
    TSX-RIO
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $5.75
  • Aug 20, 2026
    Stock
    TSXV-OMG
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $4.25
  • Aug 20, 2026
    Stock
    TSXV-MTT
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $0.30
  • Aug 20, 2026
    Stock
    TSXV-LIO
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $0.60

Live ratings from Ben Pirie and the other top‑ranked analysts, and the stocks where they agree, are in Exent Stocks Radar.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 15, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Stocks Radar shows Ben Pirie’s live ratings and those of the other top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Ben Pirie ranks #58 of 1,000 with a 5.0★ rating. 0.0% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and — of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Ben Pirie’s success rate is 59.9% by the ranking source and 0.0% by Exent’s price-target hit-rate backtest, with a median of — days to reach a target.

Ben Pirie (Atrium Research) covers 34 stocks, mostly in materials. The most frequently rated are TSXV-OMG, TSX-MSA, TSXV-CAPT, TSXV-SPA, TSXV-MTT.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.